These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17310551)

  • 1. HBV treatment: the hazy endpoint.
    Acharya SK
    Trop Gastroenterol; 2006; 27(3):103-4. PubMed ID: 17310551
    [No Abstract]   [Full Text] [Related]  

  • 2. [Challenges regarding the treatment of viral hepatitis B].
    Zhang DF
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):481-2. PubMed ID: 16042876
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B virus escape mutants induced by antiviral therapy.
    Sheldon J; Soriano V
    J Antimicrob Chemother; 2008 Apr; 61(4):766-8. PubMed ID: 18218641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-HBV effect of sulfated polysaccharides from seaweed both in vitro and in vivo].
    Wei W; Cong J; Wang M; Teng L; Li Z; Chen H; Wu K; Sun C
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):112. PubMed ID: 11983127
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of entecavir treatment on HBV-specific immunity in patient with chronic hepatitis B and its relationship to HBeAg sero-conversion].
    Li JX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):122-3. PubMed ID: 18574534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
    Wiegand J; Hasenclever D; Tillmann HL
    Antivir Ther; 2008; 13(2):211-20. PubMed ID: 18505172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of HBeAg-positive patients with nucleos/tide analogues.
    Coffin CS; Lee SS
    Liver Int; 2009 Jan; 29 Suppl 1():116-24. PubMed ID: 19207974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surrogate end-points for treatment trials of hepatitis B virus.
    Griffiths PD
    Rev Med Virol; 2010 Jul; 20(4):199-201. PubMed ID: 20586100
    [No Abstract]   [Full Text] [Related]  

  • 9. Changing landscape of antiviral resistance management in chronic hepatitis B.
    Nguyen T; Locarnini S; Desmond P
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hepatitis B virus-infected patients: utility of therapeutic recommendations in developing countries.
    Akbar SM; Hiasa Y; Mishiro S; Onji M
    Expert Opin Pharmacother; 2009 Jul; 10(10):1605-14. PubMed ID: 19496738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
    Wang FS; Zhang Z
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variability of hepatitis B virus and response to antiviral therapy.
    Liu CJ; Kao JH
    Antivir Ther; 2008; 13(5):613-24. PubMed ID: 18771045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus genotypes: an overview.
    Mahtab MA; Rahman S; Khan M; Karim F
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):457-64. PubMed ID: 18842489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.
    Tanaka E; Matsumoto A; Yoshizawa K; Maki N
    Intervirology; 2008; 51 Suppl 1():3-6. PubMed ID: 18544941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF
    Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy in HBe-Ag-positive hepatitis B with normal aminotransferase levels.
    Geier A; Dietrich CG; Gartung C
    Hepatology; 2003 Mar; 37(3):712-3; author reply 713. PubMed ID: 12601370
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial overview: Antiviral strategies: Virological and immunological basis for HBV cure.
    Urban S; Bertoletti A
    Curr Opin Virol; 2018 Jun; 30():iv-vi. PubMed ID: 29866361
    [No Abstract]   [Full Text] [Related]  

  • 20. [A comparative study on methods for detecting low level HBV markers in serum].
    Luo Y; Zhou Z; Liu Q
    Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):132. PubMed ID: 16494785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.